Highlighting the Potential of LyeTx I, a Peptide Derived from the Venom of the Spider <i>Lycosa erythrognatha</i>, as a Potential Prototype for the Development of a New Antimicrobial Against Carbapenem-Resistant <i>Klebsiella pneumoniae</i>

<b>Background</b>: Carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP) is a multidrug-resistant (MDR) gram-negative bacterium frequently involved in hospital-acquired pneumonia. The infection caused by this superbug has spread quickly in health centers worldwide, leading to high mortality rates...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	William Gustavo Lima, Amanda Souza Félix, Felipe Rocha da Silva Santos, Fernanda de Lima Tana, Amanda Neves de Souza, Rodrigo Moreira Verly, Maria Elena de Lima
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2025-05-01
Rangatū:	Pharmaceuticals
Ngā marau:	carbapenem-resistant <i>Klebsiella pneumoniae</i> superbug antimicrobial peptides spider venom pneumonia antimicrobial therapy
Urunga tuihono:	https://www.mdpi.com/1424-8247/18/5/679
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!